NCT01221480
Completed
Not Applicable
Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.
ConditionsCOPD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COPD
- Sponsor
- University of Dundee
- Enrollment
- 5977
- Primary Endpoint
- All-cause Mortality
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Data collected through TARDIS database
Exclusion Criteria
- •History of asthma or malignancy. Less than 50 years of age
Outcomes
Primary Outcomes
All-cause Mortality
Time Frame: 3000 days
All-cause Mortality
Secondary Outcomes
- Hospital Admissions(3000 days)
- COPD exacerbations(3000 days)
Similar Trials
Unknown
Not Applicable
Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart FailureHeart FailureNCT00832442Royal Brompton & Harefield NHS Foundation Trust18,240
Unknown
Not Applicable
Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary SyndromeActue Coronary SyndromeNCT03658577Shenzhen People's Hospital582
Completed
Not Applicable
β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart FailureAcute Myocardial InfarctionNCT02786654University of Leeds179,810
Completed
Phase 4
Beta Blockade in in Traumatic Brain InjuryBrain Injuries, TraumaticNCT02957331University of Tennessee26
Completed
Not Applicable
The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)Myocardial InfarctionNCT00430612Northwestern University7,057